The Thermalytix screening is a simple, non-contact process. It involves the use of a high-resolution thermal sensing device that captures thermal images without any radiation or pressure applied to the breast. The whole process is privacy-conscious, comfortable, and typically completed within minutes.

Yes, we are aware of the FDA’s warning about thermography. It’s important to note that Thermalytix is a more advanced technology that combines thermal imaging with artificial intelligence for more accurate readings, and it complies with regulatory standards, including having obtained CE Marking for European countries.

The novelty of this solution lies in its proprietary Thermalytix technology, which uses a unique AI algorithm to analyze thermal images and detect early signs of breast cancer, often before physical symptoms develop or before they are detectable by traditional methods.

While both use thermal imaging, Thermalytix incorporates artificial intelligence to enhance the accuracy and predictive power of thermal analysis, overcoming some of the limitations of conventional thermography.

During breast screening, thermal images of the breasts are taken using a high-resolution thermal camera. These images are then analyzed by AI algorithms for abnormalities that may indicate the presence of breast cancer.

The ideal time for screening is one week after your menstrual period ends when the breasts are least likely to be tender or swollen, providing more consistent results.

Breast Screening is available at Dr Vaidya’s Laboratory, Naupada, Thane. Please visit our website or contact us for information on the nearest screening centre to you.

While there is no absolute minimum age for screening, it is typically recommended for women aged 25 and above. However, if you have a family history of breast cancer, discuss with your healthcare provider whether you should be screened earlier.

No, Thermalytix screening is completely painless as it is non-contact and does not require any compression of the breasts.

Yes, Thermalytix has obtained regulatory clearances including a CE Mark for European countries and complies with international standards such as ISO 13485 and MDSAP.

Having a relative with breast cancer can increase your risk. It is important to discuss your family history with a healthcare provider, who can guide you on appropriate screening strategies and risk reduction measures.

Screening frequency can depend on several factors, including age, family history, and genetic predisposition. Generally, an annual screening is recommended, but please consult with your healthcare provider for personalized advice.

To ensure accurate results, avoid heavy exercise, hot showers, or applying lotions or deodorants on the breasts before the screening. It’s also advisable to wear comfortable clothing and avoid caffeine for a few hours before the appointment.

The ideal age to start breast cancer screening varies, but most guidelines suggest starting at the age 30 to 50 for the general population. If you have a higher risk due to family history or other factors, your doctor may recommend starting earlier. Always consult with a healthcare provider to determine the best schedule for you.